Analyst Research: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

34.14USD
1 Oct 2014
Price Change (% chg)

$0.26 (+0.77%)
Prev Close
$33.88
Open
$33.98
Day's High
$34.57
Day's Low
$33.52
Volume
816,215
Avg. Vol
658,815
52-wk High
$39.94
52-wk Low
$27.51

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Trading Report for (ACOR). A detailed report, including free correlated market analysis, and updates. 1 Oct 2014 Stock Traders Daily 13 20.00
Thomson Reuters Stock Report - ACORDA THERAPEUTICS, INC. (ACOR-O) 1 Oct 2014 Thomson Reuters Stock Report 12 25.00
ACOR: Due Diligence Review: Forensic Earnings and Valuation 30 Sep 2014 New Constructs, LLC 9 25.00
ValuEngine Rating and Forecast Report for ACOR 28 Sep 2014 ValuEngine, Inc. 11 25.00
Acorda Therapeutics 27 Sep 2014 S&P Capital IQ Quantitative Report 11 127.00
ACORDA THERAPTUTICS INC (ACOR) 12-months forecast 26 Sep 2014 Pechala's Reports 1 15.00
ACORDA THERAPTUTICS INC (ACOR) - REPORT FOR ACTIVE TRADERS 26 Sep 2014 Pechala's Reports 1 25.00
Our Economy without Stimulus; forward observations. 26 Sep 2014 Stock Traders Daily 102 20.00
Value Graph: ACORDA THERAPEUT -- ACOR 25 Sep 2014 Ford Investor Services, Inc. 1 12.00
TheStreet.com Ratings Stock Report For: ACORDA THERAPEUTICS INC (ACOR) 20 Sep 2014 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Ron Cohen

58 President,Chief Executive Officer, Director

Michael Rogers

54 2013 Chief Financial Officer

Lauren Sabella

53 2010 Executive Vice President - Commercial Development

Andrew Blight

63 2004 Chief Scientific Officer

Jane Wasman

57 2012 President - International, General Counsel, Corporate Secretary
Search Stocks